Dermatoses of the world: Burden of skin disease and associated socioeconomic status in the world - 11/01/21
Doi : 10.1016/j.jaad.2020.05.157
Rachel L. Giesey, DO a, ⁎ 
, Sino Mehrmal, BSN b, Prabhdeep Uppal, MS b, Maria E. Delost, PhD c, Gregory R. Delost, DO d, e
, Sino Mehrmal, BSN b, Prabhdeep Uppal, MS b, Maria E. Delost, PhD c, Gregory R. Delost, DO d, e a Ohio University Heritage College of Osteopathic Medicine, Athens, Ohio
b Midwestern University, Arizona College of Osteopathic Medicine, Glendale, Arizona
c Department of Health Professions, Youngstown State University, Youngstown, Ohio
d Apex Dermatology and Skin Surgery Center, Mayfield Heights, Ohio
e Lake Erie College of Osteopathic Medicine, Erie, Pennsylvania
∗Correspondence to: Rachel Giesey, DO, Department of Dermatology, University Hospitals Cleveland Medical Center, 11100 Euclid Ave, Lakeside 3500, Cleveland, OH 44106Department of DermatologyUniversity Hospitals Cleveland Medical Center11100 Euclid AveLakeside 3500ClevelandOH44106
| Funding sources: This research was conducted as part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD), coordinated by the Institute for Health Metrics and Evaluation. The GBD was partially funded by the Bill & Melinda Gates Foundation; the funders had no role in the study design, data analysis, data interpretation, or writing of the report. All authors are collaborators with the GBD. This article was not developed with consultation or support with the GBD research team. |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: Not applicable. |
|
| Reprints not available from the authors. |
© 2020
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 84 - N° 2
P. 556-559 - février 2021 Retour au numéro
Article précédent
- A pilot study of the impact of facial skin protectants on qualitative fit testing of N95 masks
- Ai-Tram N. Bui, Zizi Yu, Karen Lee, Sara J. Li, William G. Tsiaras, Sherry H. Yu, Nicole R. LeBoeuf, Arash Mostaghimi
- A single-center, retrospective record review of malignancy prevalence in patients with dermatomyositis with anti-transcription intermediary factor 1? antibodies via line immunoassay versus immunoprecipitation
- Skylar Westerdahl, Christopher M. Hull, Jennie T. Clarke, Christopher B. Hansen, Jamie L.W. Rhoads
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?